Duncan McHale
Independent Member of the Supervisory BoardDr. Duncan McHale, M.B.B.S., MRCP, M.D., Ph.D., serves as Independent Member of the Supervisory Board at Evotec SE since June 2024. He is the Founder and Director of Weatherden Ltd, based in London, UK, a position he has held since 2017. Prior to this, Dr. McHale served as Chief Medical Officer at Evelo Biosciences, Inc. from February 08, 2018 until 2023. Dr. McHale joined the Evelo Biosciences, Inc. on February 08, 2018. Dr. McHale was Venture Partner of SV Health Investors, LLC since joining the firm in 2020 to 2023. From 2011 to 2017, he was the Vice President and Head of Global Exploratory Development at UCB. Between 2008 and 2011, he held various positions at AstraZeneca, culminating in the role of Vice President of Personalized Healthcare and Biomarkers. His career also includes several roles at Pfizer from 1999 to 2007, with his most recent position being Executive Director, European Head of Molecular Profiling and TA lead for Pain, Sex Health and Urology at Pfizer Global Research and Development’s Sandwich Laboratories. Dr. McHale has M.B.B.S. from Newcastle University and Ph.D. in Genetics from Leeds University Union.
Positions
- Company NameEvotec SEStock CodeEVOPositionIndependent Member of the Supervisory BoardColleagues
- CWChristian WojczewskiCEO & Chairperson of the Management Board
- DWDieter WeinandIndependent Chairman of the Supervisory Board
- ADAurelie DalbiezChief People Officer & Member of Management Board
- CHClaire HinshelwoodCFO & Member of Management Board
- IMIngrid MllerCOO & Member of Management Board
- JHJoanna HolbrookChief Scientific Officer & Member of the Management Board
- RSRoland SackersIndependent Vice Chairperson of the Supervisory Board
- CUConstanze Ulmer-EilfortIndependent Member of Supervisory Board
- WPWesley Potter WheelerIndependent Member of the Supervisory Board
- DMDuncan McHaleIndependent Member of the Supervisory Board
- Company NameEvelo Biosciences, Inc.Stock CodeEVLOPositionChief Medical Officer
